PFAS Study Seen Bolstering Medical Monitoring Requests (1)

Oct. 11, 2022, 6:21 PM UTCUpdated: Oct. 11, 2022, 7:22 PM UTC

A recently released federal PFAS exposure report is likely to be submitted in toxic tort cases, but influence only certain medical monitoring claims, attorneys say.

A Centers for Disease Control and Prevention (CDC) agency’s final report documented the exposure to seven per- and polyfluoroalkyl substances (PFAS) in drinking water in 10 communities near military sites.

Average blood levels of one PFAS, perfluorohexane sulfonic acid (PFHxS), were higher than national levels in all 10 communities, CDC’s Agency for Toxic Substances and Disease Registry (ATSDR) found. Average blood levels of two other PFAS, perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), were higher ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.